Covered recipient · General Payments record
ASTRID CLAIRE WERNER
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$2,470.88
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $732.38 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $467.08 | 7 |
| Tarsus Pharmaceuticals, Inc. | $154.11 | 4 |
| Alcon Laboratories Inc | $45.32 | 2 |
| Bausch & Lomb Americas Inc. | $36.70 | 2 |
| GLAUKOS CORPORATION | $29.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $111.74 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106326889 | CMS |
| ABBVIE INC. | $71.59 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106326891 | CMS |
| ABBVIE INC. | $111.85 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106326893 | CMS |
| ABBVIE INC. | $124.65 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106326895 | CMS |
| ABBVIE INC. | $29.98 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106326897 | CMS |
| ABBVIE INC. | $12.84 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106326899 | CMS |
| ABBVIE INC. | $4.43 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106326901 | CMS |
| Alcon Vision LLC | $21.97 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110650241 | CMS |
| Alcon Vision LLC | $23.35 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110650243 | CMS |
| Bausch & Lomb Americas Inc. | $17.97 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140306980 | CMS |
| Bausch & Lomb Americas Inc. | $18.73 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140306978 | CMS |
| Glaukos Corporation | $29.17 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151989322 | CMS |
| Tarsus Pharmaceuticals, Inc. | $37.75 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139140430 | CMS |
| Tarsus Pharmaceuticals, Inc. | $38.78 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139140432 | CMS |
| Tarsus Pharmaceuticals, Inc. | $37.59 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139140434 | CMS |
| Tarsus Pharmaceuticals, Inc. | $39.99 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139140436 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.